JP2015516389A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015516389A5 JP2015516389A5 JP2015505723A JP2015505723A JP2015516389A5 JP 2015516389 A5 JP2015516389 A5 JP 2015516389A5 JP 2015505723 A JP2015505723 A JP 2015505723A JP 2015505723 A JP2015505723 A JP 2015505723A JP 2015516389 A5 JP2015516389 A5 JP 2015516389A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- heteroaryl
- aryl
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C[C@@](c1ccccc1N1*)(C1=O)c(cccc1)c1O Chemical compound *C[C@@](c1ccccc1N1*)(C1=O)c(cccc1)c1O 0.000 description 15
- JUWARPMAUXAPAA-QFIPXVFZSA-N COC[C@@](c1ccccc1N1Cc2ccc(C(F)(F)F)[o]2)(C1=O)c(cc1OCOc1c1)c1O Chemical compound COC[C@@](c1ccccc1N1Cc2ccc(C(F)(F)F)[o]2)(C1=O)c(cc1OCOc1c1)c1O JUWARPMAUXAPAA-QFIPXVFZSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Oc1ccccc1 Chemical compound Oc1ccccc1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261623336P | 2012-04-12 | 2012-04-12 | |
| US61/623,336 | 2012-04-12 | ||
| PCT/US2013/030219 WO2013154712A1 (en) | 2012-04-12 | 2013-03-11 | Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015516389A JP2015516389A (ja) | 2015-06-11 |
| JP2015516389A5 true JP2015516389A5 (cg-RX-API-DMAC10.html) | 2016-04-07 |
| JP6195609B2 JP6195609B2 (ja) | 2017-09-13 |
Family
ID=47902379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015505723A Expired - Fee Related JP6195609B2 (ja) | 2012-04-12 | 2013-03-11 | 治療剤として有用なスピロ−オキソインドール化合物の不斉合成 |
Country Status (14)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20150882T1 (hr) | 2008-10-17 | 2015-09-25 | Xenon Pharmaceuticals Inc. | Spirooksindolski spojevi i njihova upotreba kao terapijska sredstva |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| PE20170202A1 (es) | 2009-10-14 | 2017-03-24 | Xenon Pharmaceuticals Inc | Metodos sinteticos para compuestos espiro-oxoindol |
| RU2596488C2 (ru) | 2010-02-26 | 2016-09-10 | Ксенон Фармасьютикалз Инк. | Фармацевтические композиции спиро-оксиндольного соединения для местного введения и их применение в качестве терапевтических агентов |
| KR20150002794A (ko) | 2012-04-12 | 2015-01-07 | 제논 파마슈티칼스 인크. | 치료제로서 유용한 스파이로-옥시인돌 화합물을 위한 비대칭적 합성 |
| WO2016109795A1 (en) | 2014-12-31 | 2016-07-07 | Concert Pharmaceuticals, Inc. | Deuterated funapide and difluorofunapide |
| AR103636A1 (es) | 2015-02-05 | 2017-05-24 | Teva Pharmaceuticals Int Gmbh | Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol |
| WO2017180248A1 (en) * | 2016-04-15 | 2017-10-19 | William Marsh Rice University | Enantioenriched viridicatumtoxin b analogs |
| EP3468545B1 (en) | 2016-06-08 | 2026-08-05 | President and Fellows of Harvard College | Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome |
| WO2017218920A1 (en) | 2016-06-16 | 2017-12-21 | Teva Pharmaceuticals International Gmbh | Asymmetric synthesis of funapide |
| CN109311905A (zh) * | 2016-06-16 | 2019-02-05 | 泽农医药公司 | 螺-吲哚酮化合物的固态形式 |
| CN108395438A (zh) * | 2018-04-03 | 2018-08-14 | 陕西科技大学 | 一类具有抗菌活性的靛红母核螺环化合物及其合成方法 |
| WO2019226808A1 (en) | 2018-05-22 | 2019-11-28 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
| EP3801512A4 (en) | 2018-05-29 | 2022-01-19 | President and Fellows of Harvard College | COMPOSITIONS AND METHODS TO REDUCE TACTILE DYSFUNCTION, ANXIETY AND SOCIAL DISABILITIES |
| US12077512B2 (en) | 2019-03-25 | 2024-09-03 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
| CN116057045B (zh) | 2020-06-05 | 2026-06-09 | 金耐特生物制药公司 | 成纤维细胞生长因子受体激酶抑制剂 |
| US12552808B2 (en) | 2020-09-03 | 2026-02-17 | Amgen Inc. | Diol desymmetrization by nucleophilic aromatic substitution |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3723459A (en) | 1971-04-23 | 1973-03-27 | Mc Neil Labor Inc | 2-oxospiro (indoline -3,4{40 -thiochroman) derivatives |
| JPS6130554A (ja) | 1984-07-23 | 1986-02-12 | Ono Pharmaceut Co Ltd | プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤 |
| DE3608088C2 (de) | 1986-03-07 | 1995-11-16 | Schering Ag | Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten |
| JP2716986B2 (ja) | 1987-07-17 | 1998-02-18 | シエーリング アクチエンゲゼルシヤフト | 9‐ハロゲン‐(z)‐プロスタグランジン誘導体、その製法及び薬剤としてのその使用 |
| US5314685A (en) | 1992-05-11 | 1994-05-24 | Agouron Pharmaceuticals, Inc. | Anhydrous formulations for administering lipophilic agents |
| NO317155B1 (no) | 1997-02-04 | 2004-08-30 | Ono Pharmaceutical Co | <omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater |
| ATE237587T1 (de) | 1997-02-10 | 2003-05-15 | Ono Pharmaceutical Co | 11,15-o-dialkylprostaglandin-e-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese als aktiven inhaltsstoff enthalten |
| WO1999033794A1 (en) | 1997-12-25 | 1999-07-08 | Ono Pharmaceutical Co., Ltd. | φ-CYCLOALKYL-PROSTAGLANDIN E2 DERIVATIVES |
| JP4087938B2 (ja) | 1998-02-04 | 2008-05-21 | 高砂香料工業株式会社 | ヒノキチオ−ル類の分岐サイクロデキストリン包接化合物からなる抗菌剤およびそれを含有する組成物 |
| US6235780B1 (en) | 1998-07-21 | 2001-05-22 | Ono Pharmaceutical Co., Ltd. | ω-cycloalkyl-prostaglandin E1 derivatives |
| SE9900100D0 (sv) | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
| JPWO2005035498A1 (ja) | 2003-10-08 | 2006-12-21 | 住友製薬株式会社 | 含窒素二環性化合物の摂食調節剤としての用途 |
| JP2007536283A (ja) | 2004-05-05 | 2007-12-13 | ユニバイオスクリーン エス.アー. | ナフタルイミド誘導体、それらの製造方法、およびそれらの医薬組成物 |
| MY144968A (en) | 2005-04-11 | 2011-11-30 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
| AR053710A1 (es) | 2005-04-11 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos espiroheterociclicos y sus usos como agentes terapeuticos |
| SI1924264T1 (sl) | 2005-09-01 | 2013-12-31 | F. Hoffmann-La Roche Ag | Diaminopirimidini kot modulatorji p2x3 in p2x2/3 |
| WO2007081895A2 (en) * | 2006-01-09 | 2007-07-19 | Merck & Co., Inc. | Preparation of substituted 2-hydroxygibba-1(10a), 2, 4, 4b-tetraen-6-ones |
| WO2008046049A1 (en) | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain |
| WO2008046087A2 (en) | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Spiro compounds and their uses as therapeutic agents |
| EP2073806B1 (en) | 2006-10-12 | 2012-02-15 | Xenon Pharmaceuticals Inc. | Use of spiro-oxindole compounds as therapeutic agents |
| BRPI0719166A2 (pt) | 2006-10-12 | 2014-06-03 | Xenon Pharmaceuticals Inc | Derivados de espiro-oxindol tricíclicos e seus usos como agentes terapêuticos |
| GB0704846D0 (en) | 2007-03-13 | 2007-04-18 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
| WO2010045197A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals, Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| HRP20150882T1 (hr) | 2008-10-17 | 2015-09-25 | Xenon Pharmaceuticals Inc. | Spirooksindolski spojevi i njihova upotreba kao terapijska sredstva |
| US20110269788A1 (en) | 2008-12-29 | 2011-11-03 | Xenon Pharmaceuticals Inc. | Spiro-oxindole-derivatives as sodium channel blockers |
| US8295257B2 (en) | 2009-03-13 | 2012-10-23 | Telcordia Technologies, Inc. | Scalable disruptive-resistant communication method |
| WO2010132352A2 (en) * | 2009-05-11 | 2010-11-18 | Xenon Pharmaceuticals Inc. | Spiro compounds and their use as therapeutic agents |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| PE20170202A1 (es) | 2009-10-14 | 2017-03-24 | Xenon Pharmaceuticals Inc | Metodos sinteticos para compuestos espiro-oxoindol |
| US20110086899A1 (en) | 2009-10-14 | 2011-04-14 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions for oral administration |
| RU2596488C2 (ru) | 2010-02-26 | 2016-09-10 | Ксенон Фармасьютикалз Инк. | Фармацевтические композиции спиро-оксиндольного соединения для местного введения и их применение в качестве терапевтических агентов |
| KR20150002794A (ko) | 2012-04-12 | 2015-01-07 | 제논 파마슈티칼스 인크. | 치료제로서 유용한 스파이로-옥시인돌 화합물을 위한 비대칭적 합성 |
-
2013
- 2013-03-11 KR KR1020147031580A patent/KR20150002794A/ko not_active Withdrawn
- 2013-03-11 EP EP13710961.7A patent/EP2838902B1/en active Active
- 2013-03-11 MX MX2014012266A patent/MX2014012266A/es unknown
- 2013-03-11 JP JP2015505723A patent/JP6195609B2/ja not_active Expired - Fee Related
- 2013-03-11 CA CA2869547A patent/CA2869547A1/en active Pending
- 2013-03-11 WO PCT/US2013/030219 patent/WO2013154712A1/en not_active Ceased
- 2013-03-11 US US13/794,147 patent/US9487535B2/en active Active
- 2013-03-11 EA EA201491854A patent/EA201491854A1/ru unknown
- 2013-03-11 HK HK15105599.7A patent/HK1205114A1/xx unknown
- 2013-03-11 CN CN201380030552.0A patent/CN104350057A/zh active Pending
- 2013-03-11 ES ES13710961T patent/ES2714314T3/es active Active
- 2013-03-11 AU AU2013246485A patent/AU2013246485A1/en not_active Abandoned
- 2013-03-11 CN CN201610207838.7A patent/CN105753877A/zh active Pending
- 2013-03-11 HK HK15105598.8A patent/HK1205113A1/xx unknown
-
2014
- 2014-10-06 IL IL235006A patent/IL235006A0/en unknown
- 2014-10-09 ZA ZA2014/07334A patent/ZA201407334B/en unknown
-
2015
- 2015-06-12 HK HK16114577.4A patent/HK1226389A1/zh unknown
-
2016
- 2016-09-14 US US15/265,549 patent/US20170066777A1/en not_active Abandoned